Showing results (2091-2100 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|February 24, 2024
The Chimeric Chaoyang-Zika Vaccine Candidate Is Safe and Protective in MiceHao-Long Dong, Zhi-Li Chen, Mei-Juan He, et al.
Vaccines|February 24, 2024
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic FrontiersEnrique Álvarez, Michela Falqui, Laura Sin, et al.
Vaccines|February 24, 2024
Assessment of BoAHV-1 Seronegative Latent Carrier by the Administration of Two Infectious Bovine Rhinotracheitis Live Marker Vaccines in CalvesStefano Petrini, Cecilia Righi, Giulia Costantino, et al.
Vaccines|February 24, 2024
Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal MiceMonalisa Martins Trentini, Dunia Rodriguez, Alex Issamu Kanno, et al.
Vaccines|February 24, 2024
Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and OpportunitiesSamer Al-Dury, Nelly Kanberg
Vaccines|February 24, 2024
Human Papillomavirus (HPV) Vaccine Coverage and Confidence in Italy: A Nationwide Cross-Sectional Study, the OBVIOUS ProjectMarco Montalti, Aurelia Salussolia, Angelo Capodici, et al.
Vaccines|February 24, 2024
Sustainable Dengue Prevention and Management: Integrating Dengue Vaccination Strategies with Population PerspectivesAsrul Akmal Shafie, Edson Duarte Moreira, Gabriela Vidal, et al.
Vaccines|February 24, 2024
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in GreenlandKristiana Alexandrova Nikolova, Mikael Andersson, Hans-Christian Slotved, et al.
Vaccines|February 24, 2024
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman PrimatesSarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, et al.
Vaccines|February 24, 2024
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 TrialJihai Tang, Qinghua Xu, Chaoyin Zhu, et al.
Pageof 1,039